CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
March 09, 2023 16:15 ET
|
CytoSorbents
Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2022 continues in Q1 2023 to date, with expectation of sales growth in 2023 PRINCETON, N.J., March...
New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
March 07, 2023 07:00 ET
|
CytoSorbents
PRINCETON, N.J., March 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
CytoSorbents Appoints Dr. Rainer Kosanke as European Director of Scientific Affairs
July 08, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., July 8, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company commercializing its European Union approved CytoSorb® blood filter...
CytoSorbents Announces Start of $1M US Army Phase II SBIR Contract and Closing of Additional Funding
June 27, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 27, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused
company commercializing its European Union approved CytoSorb®...
CytoSorbents Announces FDA Approved US Air Force Funded Human Trauma Pilot Study for Rhabdomyolysis
June 17, 2013 08:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 17, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With Hitit Medical Systems in Turkey
June 13, 2013 09:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., June 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Reports 2013 First Quarter Financial Results
May 16, 2013 07:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 16, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO) is a critical care focused company using blood purification to treat life-threatening illnesses in the...
Kathleen P. Bloch Appointed as Chief Financial Officer of CytoSorbents
May 13, 2013 08:00 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 13, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With L.IN.C. Medical Systems in the United Kingdom and Ireland
May 06, 2013 08:01 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 6, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care focused therapeutic device company using blood purification to treat life-threatening...
CytoSorbents CEO Provides Exclusive Interview With medGadget
May 01, 2013 09:30 ET
|
CytoSorbents
MONMOUTH JUNCTION, N.J., May 1, 2013 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (OTCBB:CTSO), a critical care-focused company using blood purification to treat life-threatening illnesses, announced...